2022
DOI: 10.1016/s2666-5247(22)00190-2
|View full text |Cite
|
Sign up to set email alerts
|

Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(14 citation statements)
references
References 5 publications
0
14
0
Order By: Relevance
“…There are nearly one-fifth of pregnant women are diagnosed with GDM in mainland China [ 25 ], which is significantly higher than global average estimates [ 26 ], providing the feasibility of population basis for this study. With the resurgence of mycoplasma infection, especially in infants and children this autumn, continuous surveillance has been again put on the agenda [ 27 ]. Based on our pregnancy cohort, we found that genital Mollicutes varied in different stages of GDM pregnancies, which was similar to previous study [ 28 ].…”
Section: Discussionmentioning
confidence: 99%
“…There are nearly one-fifth of pregnant women are diagnosed with GDM in mainland China [ 25 ], which is significantly higher than global average estimates [ 26 ], providing the feasibility of population basis for this study. With the resurgence of mycoplasma infection, especially in infants and children this autumn, continuous surveillance has been again put on the agenda [ 27 ]. Based on our pregnancy cohort, we found that genital Mollicutes varied in different stages of GDM pregnancies, which was similar to previous study [ 28 ].…”
Section: Discussionmentioning
confidence: 99%
“…Zhang YY 2016 6 39 0.08 Infection with and Carriage of Mycoplasma pneumoniae in Children [13] Front Microbiol Sauteur PMM 2016 7 35 0.02 Clinical manifestations in infants and children with Mycoplasma pneumoniae infection [14] PLoS One Sondergaard MJ 2018…”
Section: Rankmentioning
confidence: 99%
“…The specific epidemic pattern of M. pneumoniae is characterized by epidemics every few years owing to reduced herd immunity. [10] In the past several years, the use of NPIs to control the spread of COVID-19 worldwide has resulted in a drastically reduced incidence of multiple respiratory tract infections, such as influenza, respiratory syncytial virus, and M. pneumoniae. [11,12] The worldwide incidence of M. pneumoniae before the COVID-19 pandemic (between April 1, 2017, and March 31, 2020) was 8.61%.…”
Section: A High Incidence Of M Pneumoniae Was Observed Worldwide Afte...mentioning
confidence: 99%
“…[12] The incidence of M. pneumoniae decreased to 1.69% following the implementation of NPIs, between April 1, 2020, and March 31, 2021. [10,13] The mean incidence of M. pneumoniae was 0.7% in 20 countries in Europe, Asia, the Americas, and Oceania between 2021 and 2022. [10] Global prospective surveillance indicated that the incidence of M. pneumoniae was 0.82% between April 1, 2022, and March 31, 2023.…”
Section: A High Incidence Of M Pneumoniae Was Observed Worldwide Afte...mentioning
confidence: 99%
See 1 more Smart Citation